Serge Saxonov, Chief Executive Officer at 10x Genomics, Inc. (TXG), sold 15,884 shares at $10.63 ($169K) on 2025-02-28, disclosed to the SEC on 2025-03-04.
Scheduled sale ($169k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.63 | 7,942 | $84K | 50.0% |
| 2 | $10.63 | 7,942 | $84K | 50.0% |
| Total | $10.63 avg | 15,884 | $169K | 100% |
| Filing → |
| TXG | SELL | 2026-08-26 | $1.2M | — | Filing → |
| TXG | SELL | 2026-06-24 | $1.0M | — | Filing → |
| TXG | SELL | 2026-05-27 | $709K | — | Filing → |